All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Rob Kandels's TRT results video fact-checked

rob_kandels

TikTok creator

13.6K viewsWatch on TikTok→

Quick answer

Rob, 26, reports total testosterone of 897 ng/dL and free testosterone of 25 (unit unspecified) while on TRT. These values fall in the high-normal range per AUA and Endocrine Society standards, though mid-normal targets of 400-700 ng/dL are typically preferred for hypogonadal patients under clinical guidelines. No baseline pre-treatment values, monitoring labs such as hematocrit or estradiol, or clinical indication for TRT at his age were disclosed.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.

What did @rob_kandels actually say?

Pretty brief, honestly. Rob is 26 years old and sharing his testosterone lab results while on TRT. He reports a total testosterone of 897 ng/dL and a free testosterone of 25, though he doesn't specify the unit for that free T number. He invites viewers to weigh in with their thoughts. That's the whole video. No dose disclosed, no reason for starting TRT, no context about where he was before treatment.

The lack of context is worth flagging right away. We don't know his pre-treatment baseline, his injection frequency, his ester type, or what symptoms prompted him to start TRT at 26. Those details matter enormously when evaluating whether these numbers are appropriate, conservative, or aggressive for his age.

Does the science back this up?

The numbers he's sharing are within the range most clinicians would consider acceptable for a man on TRT, but "acceptable" doesn't mean optimal or risk-free, especially at 26.

According to the American Urological Association (AUA) 2018 guidelines, a total testosterone of 897 ng/dL sits comfortably in the mid-to-high normal adult male reference range, which most major labs peg at roughly 300 to 1000 ng/dL. The Endocrine Society's clinical practice guidelines (Bhasin et al., 2018, Journal of Clinical Endocrinology and Metabolism) recommend targeting mid-normal levels, generally 400 to 700 ng/dL, for most hypogonadal patients. At 897, Rob is on the higher end of that spectrum but not wildly outside it.

Free testosterone at 25 is harder to interpret without the unit. If that's 25 pg/mL, it's elevated but not alarming. If it's 25 ng/dL, that's a different story entirely. This ambiguity is a real problem with how lab results get shared on social media.

What did they get wrong (or right)?

Rob gets credit for one thing: sharing actual lab numbers rather than just vibes. Most TRT content on TikTok is anecdote soup, so seeing a real result is at least a starting point for a real conversation.

What he got wrong, or at least incomplete, is the framing. A total T of 897 on TRT at age 26 raises some legitimate clinical questions he doesn't address. First, why TRT at 26? The Endocrine Society guidelines emphasize that TRT in younger men requires careful evaluation because exogenous testosterone suppresses the hypothalamic-pituitary-gonadal (HPG) axis, which can impair fertility and, in younger men, may affect long-term testicular function (Ramasamy et al., 2014, Fertility and Sterility). Second, he provides no hematocrit or estradiol data, both of which are standard monitoring parameters under any responsible TRT protocol. Elevated hematocrit is one of the most common adverse effects of testosterone therapy and a real cardiovascular risk factor (Calof et al., 2005, Journals of Gerontology).

Presenting half a lab panel as "results" is misleading by omission, even if unintentionally.

What should you actually know?

If you're a young man watching this video and thinking about TRT, here's what the research actually says: TRT is an FDA-approved treatment for hypogonadism, defined clinically as consistently low testosterone paired with symptoms. It is not a general performance optimization tool, and starting it at 26 without a confirmed diagnosis carries real tradeoffs.

Fertility suppression is not a minor side effect. A study by Ramasamy et al. (2014, Fertility and Sterility) found that exogenous testosterone can significantly reduce sperm production, and while this is sometimes reversible, recovery is not guaranteed, particularly with prolonged use. Men who want biological children should have a serious conversation with a urologist or reproductive endocrinologist before starting TRT.

Beyond fertility, any responsible TRT protocol involves monitoring beyond just total and free testosterone. That includes estradiol, hematocrit, PSA (even in younger men at baseline), and lipid panels. Rob sharing two numbers without this context doesn't give anyone enough information to evaluate whether his protocol is being managed responsibly.

If you have genuine symptoms of low testosterone, including fatigue, low libido, depression, and reduced muscle mass, get tested through a legitimate clinical pathway, not a social media recommendation. A confirmed diagnosis, proper baseline labs, and ongoing monitoring are what separate legitimate TRT from hormone experimentation.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

TRT social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 9 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For Rob Kandels's TRT results video fact-checked, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

Rob Kandels's TRT results video fact-checked is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

Compare providers, services and access requirements in the directory before contacting a suitable care team.

Claim path

Keep researching this testosterone and trt video claims cluster

Best for searchers turning TRT social claims into a safer lab-backed provider discussion.

Claim verdict

The useful answer behind this video

Claim being checked

Rob, 26, reports total testosterone of 897 ng/dL and free testosterone of 25 (unit unspecified) while on TRT.

FormBlends verdict

Rob, 26, reports total testosterone of 897 ng/dL and free testosterone of 25 (unit unspecified) while on TRT. These values fall in the high-normal range per AUA and Endocrine Society standards, though mid-normal targets of 400-700 ng/dL are typically preferred for hypogonadal patients under clinical guidelines. No baseline pre-treatment values, monitoring labs such as hematocrit or estradiol, or clinical indication for TRT at his age were disclosed.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • Rob, 26, reports total testosterone of 897 ng/dL and free testosterone of 25 (unit unspecified) while on TRT. These values fall in the high-normal range per AUA and Endocrine Society standards, though mid-normal targets of 400-700 ng/dL are typically preferred for hypogonadal patients under clinical guidelines. No baseline pre-treatment values, monitoring labs such as hematocrit or estradiol, or clinical indication for TRT at his age were disclosed.
  • 897 ng/dL total testosterone is within normal adult male reference range (300-1000 ng/dL per most labs) but sits above the 400-700 ng/dL mid-normal target recommended by the Endocrine Society (Bhasin et al., 2018, JCEM) for most TRT patients.
  • Free testosterone numbers without units are clinically meaningless. 25 pg/mL and 25 ng/dL represent vastly different physiological states, and this distinction matters when evaluating lab results.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • 897 ng/dL total testosterone is within normal adult male reference range (300-1000 ng/dL per most labs) but sits above the 400-700 ng/dL mid-normal target recommended by the Endocrine Society (Bhasin et al., 2018, JCEM) for most TRT patients.
  • Free testosterone numbers without units are clinically meaningless. 25 pg/mL and 25 ng/dL represent vastly different physiological states, and this distinction matters when evaluating lab results.
  • TRT suppresses the hypothalamic-pituitary-gonadal axis in younger men. Ramasamy et al. (2014, Fertility and Sterility) found this can impair sperm production in ways that are not always reversible.
  • Complete TRT monitoring requires more than two numbers. Hematocrit, estradiol, PSA, and lipid panels are standard components of responsible ongoing care, per AUA 2018 guidelines.
  • Elevated hematocrit from testosterone therapy is a documented cardiovascular risk. Calof et al. (2005, Journals of Gerontology) identified it as one of the most consistent adverse effects requiring routine blood monitoring.
  • TRT is FDA-approved specifically for hypogonadism, a clinical diagnosis requiring consistently low testosterone plus symptoms. It is not approved or studied as a general performance or optimization intervention in otherwise healthy young men.
  • Anyone considering TRT should get baseline labs including LH, FSH, and prolactin, not just testosterone, to rule out secondary causes before starting therapy.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

rob_kandels · TikTok creator

13.6K views on this video

Here are my TRT Results#fitnesstips #fitips #workouttips #fittipsdaily #fitness #workout #bodybuilding #SearchForWonderMom #BBPlayDate

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by rob_kandels, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.